𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy

✍ Scribed by G. Okunade; A.R. Green; M. Ying; A. Agrawal; E.C. Paish; M. Aleskandrany; L. Winterbottom; K. Hassell; D.A.L. Morgan; I.O. Ellis; K.L. Cheung

Book ID
108110163
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
337 KB
Volume
72
Category
Article
ISSN
1040-8428

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prediction of response to endocrine ther
Prediction of response to endocrine therapy in breast cancer using immunocytochemical assays for pS2, oestrogen receptor and progesterone receptor
✍ Y. A. Luqmani; D. Ricketts; G. Ryall; L. Turnbull; M. Law; R. C. Coombes πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 802 KB

Histological sections obtained from 70 patients with breast cancer, all of whom had received endocrine therapy for metastatic or locally advanced disease, were assessed for specific immunocytochemical staining of oestrogen receptor and the oestrogen-induced protein pS2. There was also sufficient mat

Phase 2 randomized trial of primary endo
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/